FDx Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-36,198
| Closed | -$619K | – | 1084 |
|
|
2018
Q1 | $619K | Sell |
36,198
-2,667
| -7% | -$45.6K | 0.02% | 666 |
|
|
2017
Q4 | $736K | Sell |
38,865
-50,920
| -57% | -$964K | 0.02% | 649 |
|
|
2017
Q3 | $1.58M | Buy |
89,785
+13,658
| +18% | +$240K | 0.04% | 393 |
|
|
2017
Q2 | $2.53M | Buy |
76,127
+26,472
| +53% | +$879K | 0.07% | 235 |
|
|
2017
Q1 | $1.59M | Buy |
49,655
+5,987
| +14% | +$192K | 0.05% | 362 |
|
|
2016
Q4 | $1.58M | Buy |
43,668
+18,075
| +71% | +$655K | 0.05% | 355 |
|
|
2016
Q3 | $1.18M | Sell |
25,593
-8,247
| -24% | -$380K | 0.05% | 341 |
|
|
2016
Q2 | $1.7M | Buy |
33,840
+18
| +0.1% | +$904 | 0.08% | 232 |
|
|
2016
Q1 | $1.81M | Buy |
33,822
+13,811
| +69% | +$739K | 0.08% | 214 |
|
|
2015
Q4 | $1.31M | Buy |
20,011
+10,064
| +101% | +$661K | 0.06% | 278 |
|
|
2015
Q3 | $562K | Sell |
9,947
-4,165
| -30% | -$235K | 0.05% | 414 |
|
|
2015
Q2 | $834K | Sell |
14,112
-1,088
| -7% | -$64.3K | 0.04% | 388 |
|
|
2015
Q1 | $946K | Sell |
15,200
-961
| -6% | -$59.8K | 0.02% | 624 |
|
|
2014
Q4 | $929K | Buy |
16,161
+6,225
| +63% | +$358K | 0.06% | 329 |
|
|
2014
Q3 | $534K | Buy |
+9,936
| New | +$534K | 0.03% | 560 |
|
|
2013
Q4 | – | Sell |
-42,101
| Closed | -$1.59M | – | 668 |
|
|
2013
Q3 | $1.59M | Sell |
42,101
-1,461
| -3% | -$55.2K | 0.19% | 117 |
|
|
2013
Q2 | $1.71M | Buy |
+43,562
| New | +$1.71M | 0.23% | 105 |
|